ACCESS TO ADVANCED HEALTH INSTITUTE

SEATTLE, WASHINGTON 981023797

$12.41M
Total Contract Value
50 awards
First Award
Jun 22, 2022
Last Award
Jul 1, 2025
Business Size
other than small
CAGE Code
06UF1

Top Industries (NAICS)

NAICS CodeObligationsAwards
541714$5.79M28
541715$5.02M13
541712$-80,840.972

Contract Awards

13 awards found

75N93023C00018
Department of Health and Human Services
$110K
Sep 10, 2024

BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
75N93019C00059
Department of Health and Human Services
$113K
Sep 10, 2024

THE CONTRACTOR SHALL DEVELOP A MULTIVALENT FLAVIVIRUS VACCINE USING A FLEXIBLE REPLICATION RNA PLATFORM.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
75N93023C00018
Department of Health and Human Services
$841K
Aug 16, 2024

BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
75N93019C00059
Department of Health and Human Services
$1.92M
Jul 22, 2024

THE CONTRACTOR SHALL DEVELOP A MULTIVALENT FLAVIVIRUS VACCINE USING A FLEXIBLE REPLICATION RNA PLATFORM.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
75N93023C00018
Department of Health and Human Services
$2.83M
Jun 26, 2024

BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
75N93018C00025
Department of Health and Human Services
$1.26M
Mar 20, 2024

THE PURPOSE OF THIS CONTRACT IS TO ENABLE ADVANCED PRECLINICAL DEVELOPMENT OF AN INTRANASAL RECOMBINANT AMEBIASIS VACCINE CONTAINING A LIPOSOMAL ADJUVANT FORMULATION OF CLINICAL TLR4 AND TLR7/8 LIGANDS.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
75N93019C00059
Department of Health and Human Services
$780K
Jan 9, 2024

THE CONTRACTOR SHALL DEVELOP A MULTIVALENT FLAVIVIRUS VACCINE USING A FLEXIBLE REPLICATION RNA PLATFORM.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
75N93019C00059
Department of Health and Human Services
$1.67M
Aug 28, 2023

THE CONTRACTOR SHALL DEVELOP A MULTIVALENT FLAVIVIRUS VACCINE USING A FLEXIBLE REPLICATION RNA PLATFORM.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
75N93023C00018
Department of Health and Human Services
$426K
Aug 28, 2023

BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
75N93023C00018
Department of Health and Human Services
$810K
Jul 5, 2023

BAA RESEARCH AREA 001: DEVELOPMENT OF VACCINE CANDIDATES FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
75N93018C00025
Department of Health and Human Services
$-422.76
Jun 30, 2023

THE PURPOSE OF THIS CONTRACT IS TO ENABLE ADVANCED PRECLINICAL DEVELOPMENT OF AN INTRANASAL RECOMBINANT AMEBIASIS VACCINE CONTAINING A LIPOSOMAL ADJUVANT FORMULATION OF CLINICAL TLR4 AND TLR7/8 LIGANDS.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
HHSN272201400041C
Department of Health and Human Services
$-80,840.97
Mar 29, 2023

TO SUPPORT THE ADVANCED DEVELOPMENT OF CANDIDATE PRODUCTS, WHICH CONSIST OF A VACCINE COMPONENT IN COMBINATION WITH A DRY FORMULATION TECHNOLOGY

NAICS: 541712 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)FY2023
75N93018C00025
Department of Health and Human Services
$39K
Aug 23, 2022

THE PURPOSE OF THIS CONTRACT IS TO ENABLE ADVANCED PRECLINICAL DEVELOPMENT OF AN INTRANASAL RECOMBINANT AMEBIASIS VACCINE CONTAINING A LIPOSOMAL ADJUVANT FORMULATION OF CLINICAL TLR4 AND TLR7/8 LIGANDS.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2022

Business Details

UEI
EMQ1ANLATYS6
CAGE Code
06UF1
Address
1616 EASTLAKE AVE E STE 400
STE 400
SEATTLE, WA 981023797
Congressional District
WA-07

Parent Company

ACCESS TO ADVANCED HEALTH INSTITUTE

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov